Related Experiment Video

Updated: May 21, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Predictive Molecular Tumour Testing: What Are the Obstacles between Bench and Bedside?

Linda Mileshkin1, Bhaumik Shah, Michael Michael

  • 1Division of Cancer Medicine, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, VIC 3002, Australia.

Chemotherapy Research and Practice
|June 6, 2012
PubMed

Insights

Personalized cancer treatment is advancing due to new molecular targets like epidermal growth factor receptor (EGFR) and K-ras. Challenges in implementing these tumor tests include tissue quality, access, and interpretation consensus.

Area of Science:

  • Oncology
  • Molecular Diagnostics
  • Cancer Biology

Background:

  • Recent advances in tumor biology enable personalized treatment strategies for specific cancers.
  • Molecular targets such as epidermal growth factor receptor (EGFR) and K-ras are crucial for tumor classification and guiding therapy.
  • Clinical implementation of novel molecular tests faces several practical challenges.

Purpose of the Study:

  • To review the challenges associated with implementing molecular tests for tumor characterization in clinical practice.
  • To discuss the specific examples of epidermal growth factor receptor (EGFR) and K-ras testing.
  • To propose actionable solutions for overcoming identified barriers.

Main Methods:

  • Review of current literature and clinical practice guidelines.
  • Detailed examination of two key molecular targets: EGFR and K-ras.
  • Analysis of potential obstacles including tissue specimen quality, test accessibility, interpretation consensus, and funding.

Main Results:

  • Molecular profiling of tumors using targets like EGFR and K-ras is essential for personalized medicine.
  • Significant barriers exist in the routine clinical application of these tests.
  • These barriers include logistical, technical, and financial aspects.

Conclusions:

  • Addressing challenges in tissue quality, test availability, and interpretation is critical for successful implementation of molecular diagnostics.
  • Standardization and clear guidelines are needed to facilitate the integration of these tests into routine cancer care.
  • Proactive strategies are required to overcome obstacles and fully realize the potential of personalized cancer therapy.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...